The ATR-p53 pathway is suppressed in noncycling normal and malignant lymphocytes

Oncogene

Volumn 23, Issue 10, 2004, Pages 1911-1921

  Jones, Gillian G ^a   Reaper, Philip M ^b   Pettitt, Andrew R ^a   Sherrington, Paul D ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ATR; Cell cycle; Chronic lymphocytic leukaemia; Lymphocytes; p53

Indexed keywords

ATM PROTEIN; ATR PROTEIN; ENZYME ACTIVATOR; ENZYME ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BIOACCUMULATION; CANCER CELL CULTURE; CELL ASSAY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVATION; GENE INACTIVATION; GENE MUTATION; GENETIC STABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; IONIZING RADIATION; LYMPHOCYTE CLONE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; ULTRAVIOLET RADIATION; UPREGULATION;

BASE SEQUENCE; CELL CYCLE; CELLS, CULTURED; DNA DAMAGE; DNA PRIMERS; DNA, NEOPLASM; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOCYTES; MITOSIS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

MURINAE;

EID: 1842534256     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207318     Document Type: Article

References (66)

1. Abou-Zhar F, Bejjani B, Kruyt FAE, Kurg R, Bacino C, Shapira SK and Youssoufian H. (1999). Am. J. Med. Genet., 83, 388-391.
2. Abraham RT. (2001). Genes Dev., 15, 2177-2196.
3. Bakkenist CJ and Kastan MB. (2003). Nature, 421, 499-506.
4. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y and Ziv Y. (1998). Science, 281, 1674-1677.
5. Bean LJH and Stark GR. (2001). Oncogene, 20, 1076-1084.
6. Bernstein C, Bernstein H, Payne CM and Garewal H. (2002). Mutat. Res., 511, 145-178.
7. Blagosklonny MV. (2002). Int. J. Cancer, 98, 161-166.
8. Bogdanov KV, Chukhlovin AB, Zaritskey AY, Frolova OI and Afanasiev BV. (1997). Br. J. Haemat., 98, 869-872.
9. Brown EJ and Baltimore D. (2000). Genes Dev., 14, 397-402.
10. Brown EJ and Baltimore D. (2003). Genes Dev., 17, 615-628.
11. Brown JM and Wouters BG. (1999). Cancer Res., 59, 1391-1399.
12. Butler MG, Hall BD, Maclean RN and Lozzio CB. (1987). Am. J. Med. Genet., 27, 645-649.
13. Caligaris-Cappio F and Hamblin TJ. (1999). J. Clin. Oncol., 17, 399-408.
14. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB and Siliciano JD. (1998). Science, 281, 1677-1679.
15. Chanan-Khan A, Holkova B, Perle MA, Reich E, Wu CD, Inghirami G and Takeshita K. (2003). Haematologica, 88, ECR14.
16. Cliby WA, Roberts CJ, Cimprich KA, Stringer CM, Lamb JR, Schreiber SL and Friend SH. (1998). EMBO J., 17, 159-169.
17. Cortez D, Guntuku S, Qin J and Elledge SJ. (2001). Science, 294, 1713-1716.
18. de Boer J and Hoeijmakers JHJ. (2000). Carcinogenesis, 21, 453-460.
19. de Klein A, Muijtjens M, Os van R, Verhoeven Y, Smit B, Carr AM, Lehmann AR and Hoeijmakers JH. (2000). Curr. Biol., 10, 479-482.
20. de Laat WL, Jaspers NGJ and Hoeijmakers JHJ. (1999). Genes Dev., 13, 769-785.
21. Don RH, Cox PT, Wainwright BJ, Baker K and Mattick JS. (1991). Nucleic Acids Res., 19, 4008.
22. Fairbairn DW, Olive PL and O'Neill KL. (1995). Mutat. Res., 339, 37-59.
23. Ford JM and Hanawalt PC. (1995). Proc. Natl. Acad. Sci., USA, 92, 8872-8880.
24. Ford JM and Hanawalt PC. (1997). J. Biol. Chem., 272, 28073-28080.
25. Friedburg EC, Walker GC and Siede W. (1995). DNA Repair and Mutagenesis. ASM Press: Washington, DC.
26. Giaccia AJ and Kastan MB. (1998). Genes Dev., 12, 2973-2983.
27. Hoeijmakers JHJ. (2001). Nature, 411, 366-374.
28. Hupp TR, Sparks A and Lane DP. (1995). Cell, 83, 237-245.
29. Kapoor M, Hamm R, Yan W, Taya Y and Lozano G. (2000). Oncogene, 19, 358-364.
30. Lakin ND and Jackson SP. (1999). Oncogene, 18, 7644-7655.
31. Lawrence CW and Maher VM. (2001). Biochem. Soc. Trans., 29, 187-191.
32. Lin K, Sherrington PD, Dennis M, Matrai Z, Cawley JC and Pettitt AR. (2002). Blood, 100, 1404-1409.
33. Lozano G and Elledge SJ. (2000). Nature, 404, 24-25.
34. Lyons AB. (2000). J. Immunol. Methods, 243, 147-154.
35. Lyons AB and Parish CR. (1994). J. Immunol. Methods, 171, 131-137.
36. Meyn S. (1999). Clin. Genet., 55, 289-304.
37. Mitchell JR, Hoeijmakers JHJ and Niedernhofer LJ. (2003). Curr. Opin. Cell Biol., 15, 232-240.
38. Munch-Petersen B. (1997). Mutat. Res., 383, 143-153.
39. Nakona K, Balint E, Ashcroft M and Vousden KH. (2000). Oncogene, 19, 4283-4289.
40. Nelson WG and Kastan WB. (1994). Mol. Cell. Biol., 14, 1815-1823.
41. O'Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA and Goodship JA. (2003). Nat. Genet., 33, 497-501.
42. Peller S and Rotter V. (2003). Hum. Mutat., 21, 277-284.
43. Pettitt AR. (2003). Br. J. Haematol., 121, 692-702.
44. Pettitt AR, Stankovic T, Sherrington PD, Stewart G, Cawley JC and Taylor AMR. (2001). Blood, 98, 814-822.
45. Pfeifer GP. (1997). Photochem. Photobiol., 65, 270-283.
46. Phillips DH. (1999). Mutat. Res., 443, 139-147.
47. Prakash S and Prakash L. (2002). Genes Dev., 16, 1872-1883.
48. Sherrington PD, Fisch P, Taylor AM and Rabbitts TH. (1994). Oncogene, 9, 2377-2381.
49. Shiloh Y. (2001). Curr. Opin. Genet. Dev., 11, 71-77.
50. Shiloh Y. (2003). Nat. Rev. Cancer, 3, 155-168.
51. Smith ML and Fornace Jr AJ. (1997). Proc. Natl. Acad. Sci., USA, 94, 12255-12257.
52. Soussi T and Beroud C. (2001). Nat. Rev. Cancer, 1, 233-240.
53. Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, Moss PA and Taylor AM. (1999). Lancet, 353, 26-29.
54. Starostik P, Manshouri T, O'Brien S, Freireich E, Kantarjian H, Haidar M, Lerner S, Keating M and Albitar M. (1998). Cancer Res., 58, 4552-4557.
55. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y and Nakamura Y. (2000). Nature, 404, 42-49.
56. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C and Abraham RT. (1999). Genes Dev., 13, 152-157.
57. Tuck A, Smith S and Larcom L. (2000). Mutat. Res., 459, 73-80.
58. Tuck A, Smith S, Whitesides JF and Larcom L. (1999). Leuk. Lymph., 36, 169-177.
59. Unsal-Kacmaz K, Makhov AM, Griffith JD and Sancar A. (2002). Proc. Natl. Acad. Sci., USA, 99, 6673-6678.
60. Vousden KH and Lu X. (2002). Nat. Rev. Cancer, 2, 594-604.
61. Wang P, Spielberger RT, Thangavelu M, Zhao N. Davis EM, Iannantuoni K, Larson RA and Le Beau MM. (1997). Genes Chromosomes Cancer, 20, 282-291.
62. White E and Prives C. (1999). Nature, 399, 734-737.
63. Woodgate R. (1999). Genes Dev., 13, 2191-2195.
64. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS and Baltimore D. (1996). Genes Dev., 10, 2411-2422.
65. Zhou BB and Elledge SJ. (2000). Nature, 408, 433-439.
66. Zou L and Elledge SJ. (2003). Science, 300, 1542-1548.